U.S. Department of Health and Human Services
Oliver Blondel
 

 Contact Info

 
Tel: 301-451-7334
Email: blondelol@mail.nih.gov
 

 Select Experience

 
  • Senior ScientistHuman Genome Sciences2001-2004
  • Visiting ScientistNINDS/NIH1997-2000
  • Research AssociateINSERM U-446, Chatenay-Malabry, France1994-1997
  • Postdoctoral FellowUniversity of Chicago1990-1994
  • Ph.D.University of Paris 7, France1989

Olivier Blondel, Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities and Activities

I direct programs that study endocrine systems biology.  As such, my primary interests lie in research that focuses on endocrine signaling, stem cells, genomics, and systems and chemical biology in the context of diabetes, obesity, and metabolic diseases.  My administrative responsibilities include directing the Beta Cell Biology Consortium—a large international effort that takes a team-based approach to the development of a cell-based therapy for insulin delivery.  I also serve as the NIDDK point of contact for regenerative medicine and participate in several working groups that focus on metabolism, genetics, obesity, and bioinformatics as they relate to type 1 diabetes.

​Research Programs

Endocrine Pancreas
The Endocrine Pancreas program supports research on the basic biology, development, and function of the endocrine pancreas as well as clinical studies on islet transplantation for the treatment of type 1 diabetes

Pathophysiology of Diabetes and Metabolic Disease
This program supports basic and clinical research that addresses the pathophysiology of metabolic diseases, including the etiology of type 1 diabetes and other autoimmune endocrine diseases